Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-25 @ 4:25 AM
NCT ID: NCT07180420
Eligibility Criteria: Inclusion Criteria: * 18 to 55 years of age * Body mass index (BMI) 18 to 30 kg/m2 * Subjects who do not take prescribed or OTC medications on a regular basis. In the case of recent sporadic use for minor illness, the subject may be enrolled if the investigator deems the use insignificant to study. * Nonsmokers and subjects who smoked 10 or fewer cigarettes per day. * Be willing to spend at least 12 hours in the study facility. Exclusion Criteria: * Subjects who do not fulfill criteria as described in Inclusion Criteria above * Abnormal wrist or forearm anatomy (or history of prior wrist/forearm surgery). * Difficult venous access for blood draws * Active infection in including respiratory tract infection * Used opioid analgesics for pain relief within the previous 14 days, or, in the judgment of the investigator, had significant acute or chronic medical conditions. * Known previous or concomitant serious illness or medical condition such as malignancy, HIV, significant gastrointestinal or hepatic disease or cardiovascular event or hepatitis that in the opinion of the investigator may interfere with participation in the study * Previous Substance Use Disorder (SUD) with injectable drugs. * Compromised cardiovascular system (history of myocardial infarction- MI, angina, etc., at discretion of principal investigator- PI).
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT07180420
Study Brief:
Protocol Section: NCT07180420